Cargando…

IFITM3 Inhibits SARS-CoV-2 Infection and Is Associated with COVID-19 Susceptibility

SARS-CoV-2 has become a global threat to public health. Infected individuals can be asymptomatic or develop mild to severe symptoms, including pneumonia, respiratory distress, and death. This wide spectrum of clinical presentations of SARS-CoV-2 infection is believed in part due to the polymorphisms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Fengwen, Wang, Geng, Zhao, Fei, Huang, Yu, Fan, Zhangling, Mei, Shan, Xie, Yu, Wei, Liang, Hu, Yamei, Wang, Conghui, Cen, Shan, Liang, Chen, Ren, Lili, Guo, Fei, Wang, Jianwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692367/ https://www.ncbi.nlm.nih.gov/pubmed/36423162 http://dx.doi.org/10.3390/v14112553

Ejemplares similares

MARCH8 inhibits influenza A virus infection by targeting viral M2 protein for ubiquitination-dependent degradation in lysosomes
por: Liu, Xiaoman, et al.
Publicado: (2021)

SERINC5 restricts influenza virus infectivity
por: Zhao, Fei, et al.
Publicado: (2022)

MxB inhibits long interspersed element type 1 retrotransposition
por: Huang, Yu, et al.
Publicado: (2022)

Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate
por: Mei, Shan, et al.
Publicado: (2022)

Identification of an endocytic signal essential for the antiviral action of IFITM3
por: Jia, Rui, et al.
Publicado: (2014)

Rapid and sensitive one-tube detection of mpox virus using RPA-coupled CRISPR-Cas12 assay
por: Zhao, Fei, et al.
Publicado: (2023)

Amphotericin B Inhibits Enterovirus 71 Replication by Impeding Viral Entry
por: Xu, Fengwen, et al.
Publicado: (2016)

Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV
por: Wilkins, Jordan, et al.
Publicado: (2016)

The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19
por: Schönfelder, Kristina, et al.
Publicado: (2021)

HIV-1 mutates to evade IFITM1 restriction
por: Ding, Shilei, et al.
Publicado: (2014)

SARS‐CoV‐2‐related IFITM3 in immune dysfunction and tumor microenvironment: An integrative analysis in pan‐cancers
por: Li, Xue‐Ping, et al.
Publicado: (2021)

Opposing activities of IFITM proteins in SARS‐CoV‐2 infection
por: Shi, Guoli, et al.
Publicado: (2020)

SARS-CoV-2 evolution influences GBP and IFITM sensitivity
por: Mesner, Dejan, et al.
Publicado: (2023)

Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients
por: Dai, Yu-Jun, et al.
Publicado: (2020)

CRISPR-Cas13a Inhibits HIV-1 Infection
por: Yin, Lijuan, et al.
Publicado: (2020)

IFITM3 and Susceptibility to Respiratory Viral Infections in the Community
por: Mills, Tara C., et al.
Publicado: (2014)

Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase
por: Li, Quanjie, et al.
Publicado: (2021)

IFITM Proteins Restrict Viral Membrane Hemifusion
por: Li, Kun, et al.
Publicado: (2013)

Activation and evasion of type I interferon responses by SARS-CoV-2
por: Lei, Xiaobo, et al.
Publicado: (2020)

Interferon‐induced transmembrane protein 3 (IFITM3) limits lethality of SARS‐CoV‐2 in mice
por: Kenney, Adam D, et al.
Publicado: (2023)

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein
por: Yu, Jingyou, et al.
Publicado: (2015)

Characterization and anti-inflammation role of swine IFITM3 gene
por: Li, He-Ping, et al.
Publicado: (2017)

The C-Terminal Sequence of IFITM1 Regulates Its Anti-HIV-1 Activity
por: Jia, Rui, et al.
Publicado: (2015)

NP and NS1 proteins of H5N1 virus significantly upregulated IFITM1, IFITM2, and IFITM3 in A549 cells
por: Wang, Haifeng, et al.
Publicado: (2019)

Current Progress on Host Antiviral Factor IFITMs
por: Ren, Linzhu, et al.
Publicado: (2020)

Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
por: Kong, Qi, et al.
Publicado: (2020)

N(6)-methyladenosine regulates RNA abundance of SARS-CoV-2
por: Zhang, Ting, et al.
Publicado: (2021)

SAMHD1 Inhibits LINE-1 Retrotransposition by Promoting Stress Granule Formation
por: Hu, Siqi, et al.
Publicado: (2015)

IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro
por: Prelli Bozzo, Caterina, et al.
Publicado: (2021)

Identification of novel key amino acids at the interface of the transmembrane domains of human BST-2 and HIV-1 Vpu
por: Pang, Xiaojing, et al.
Publicado: (2013)

Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
por: Chi, Xiaojing, et al.
Publicado: (2020)

Antiviral Role of IFITM Proteins in Classical Swine Fever Virus Infection
por: Li, Cheng, et al.
Publicado: (2019)

Effects of the overexpression of IFITM5 and IFITM5 c.-14C>T mutation on human osteosarcoma cells
por: Liu, Bao-Yan, et al.
Publicado: (2017)

Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
por: Xiao, Xia, et al.
Publicado: (2020)

Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay
por: Winkler, Michael, et al.
Publicado: (2019)

Comparative analysis of the chicken IFITM locus by targeted genome sequencing reveals evolution of the locus and positive selection in IFITM1 and IFITM3
por: Bassano, Irene, et al.
Publicado: (2019)

The interferon-induced MxB protein inhibits an early step of HIV-1 infection
por: Liu, Zhenlong, et al.
Publicado: (2013)

SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation
por: Wang, Wenjing, et al.
Publicado: (2021)

Fish ACE2 is not susceptible to SARS-CoV-2
por: Xie, Shi-Zhe, et al.
Publicado: (2022)

Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
por: Yu, Fei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tn37s8ebr4i705g20fa8kdr7p1